Analysis Of Income And Expense [Abstract]

Onward Medical N.V. - Filing #5877475

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Analysis of income and expense [abstract]
Material income and expense [abstract]
Finance income (cost)	—	903,000 EUR	—	—	—	—	611,000 EUR	—	—	—
Selling, general and administrative expense [abstract]
General and administrative expense	—	12,576,000 EUR	—	—	—	—	11,327,000 EUR	—	—	—
Operating expense	—	36,579,000 EUR	—	—	—	—	35,995,000 EUR	—	—	—
Sales and marketing expense	—	3,350,000 EUR	—	—	—	—	2,943,000 EUR	—	—	—
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	434,000 EUR	—	—	—	—	155,000 EUR	—	—	—
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	– EUR	36,856,000 EUR	– EUR	434,000 EUR	37,290,000 EUR	– EUR	37,264,000 EUR	37,109,000 EUR	– EUR	155,000 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	—	36,856,000 EUR	—	—	—	—	37,264,000 EUR	—	—	—
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	—	– EUR	—	—	—	—	– EUR	—	—	—